Success Story: Indian Research Associate Earns EB-1A Approval for Advancing Global Health and Heart Disease Treatment

Client’s Testimonial:

“I have nothing but high praises for the team that handled both my EB2-NIW and EB1A petitions. Before signing the contract, the team was clear about what they would require me to add to my CV. They also carefully guided me on the people I should reach out to for my LoRs, who had never worked with me. While my EB1 petition initially got rejected, the Attorneys provided clear options on the paths I could take, eventually leading to an approval. Their reverts always came within 24 business hours, as was stated in the contract. I hope to receive notification on my EB2-NIW soon as well, so we are able to capture an earlier priority date, which was the strategy recommended by the Attorneys at Chen. Thank you so much for your guidance on such an important step in our journeys, Chen and Associates.”

On January 10^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the field of Cardiovascular Research (Approval Notice).

General Field: Cardiovascular Research

Position at the Time of Case Filing: Research Associate

Country of Origin: India

State of Residence at the Time of Filing: Ohio

Approval Notice Date: January 10^th, 2025

Processing Time: 14 days (Premium Processing Requested)

Case Summary:

We are pleased to share the EB1A approval of a research associate from India. At the time of filing, the client was conducting research in the United States focused on global and national trends in cardiovascular care, healthcare disparities, and patient outcomes. His studies have shaped clinical strategies for coronary angiography, cardiac arrest management, and transcatheter aortic valve replacement (TAVR). With an exceptional publication record, high citation impact, and international recognition, he demonstrated extraordinary ability in his field.

Extraordinary Research Contributions

The client’s research provides vital insight into treatment optimization and healthcare equity in cardiovascular medicine. His findings have informed global medical guidelines and influenced clinical practices for managing cardiac arrest and heart failure. He has led landmark analyses that refined approaches to same-day discharge following TAVR, optimized cerebral protection during cardiac interventions, and improved the management of coronary artery disease. Collectively, his work advances patient safety, procedural efficiency, and equitable access to cardiovascular care, addressing a major public health priority in the United States.

Academic Record and Recognition

The client holds an M.B.B.S. and serves as a research associate at a leading U.S. institution. He has authored 54 peer-reviewed journal articles, 50 conference abstracts, and 2 book chapters, earning over 1,100 citations from scholars in 63 countries. Thirteen of his papers rank among the top 10% most cited in Clinical Medicine.

He has completed 17 peer reviews for major journals and serves on the editorial boards of BMC Cardiovascular Disorders, Frontiers in Nephrology, and European Journal of Medical Research. His research has also received funding from the Bill & Melinda Gates Foundation, further demonstrating its global impact.

Expert Recognition

Independent experts praised the importance of his research to U.S. healthcare and global innovation.

One recommender stated:

“It is clear that [client] stands at the top of his field, given his achievements in areas such as closing gaps in healthcare access in the United States and uncovering the advantages and disadvantages of TAVR.”

This endorsement highlights both the clinical and societal relevance of his contributions.

EB1A Approval and Outlook

The I-140 EB1A petition was filed on December 27, 2024, and approved on January 10, 2025, under premium processing. With NAILG’s support, the client demonstrated sustained international acclaim and major contributions to cardiovascular medicine. He now continues his work in the United States, developing data-driven strategies to improve heart disease prevention and healthcare delivery, reinforcing America’s leadership in global medical research.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.